Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleMinireview

Does the lipid bilayer orchestrate access and binding of ligands to transmembrane orthosteric/allosteric sites of GPCRs?

Christopher Tytus Szlenk, Jeevan B GC and Senthil Natesan
Molecular Pharmacology April 8, 2019, mol.118.115113; DOI: https://doi.org/10.1124/mol.118.115113
Christopher Tytus Szlenk
Washington State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeevan B GC
Washington State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Senthil Natesan
Washington State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Senthil Natesan
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

For many G protein-coupled receptors (GPCRs), ligand-binding sites are deeply embedded within and around the central pocket formed by their seven transmembrane-spanning α-helical domains. Traditionally, these binding sites are thought to be accessible to endogenous ligands from the aqueous phase. Recent advances in structural biology of GPCRs, along with biophysical and computational studies suggest that amphiphilic and lipophilic molecules may gain access to these receptors by first partitioning into the membrane and then reaching via lateral diffusion through the lipid bilayer. In addition, several crystal structures of class A and class B GPCRs bound to their ligands offer unprecedented details on the existence of lipid-facing allosteric binding sites outside the transmembrane helices that can be reached only via lipid pathways. The highly ordered structure of the lipid bilayer may guide lipophilic or amphiphilic drug molecule to a specific depth within the bilayer, affecting its local concentration near the binding site, and influencing its binding kinetics. Additionally, the constraints of the lipid bilayer including its composition and biophysical properties might play a critical role in "pre-organizing" ligand molecules in apposite orientation and conformation to facilitate receptor binding. Despite its conspicuous involvement in molecular recognition processes, the critical role of membrane in ligand-binding mechanism to lipid-exposed transmembrane binding sites remains poorly understood, and warrants comprehensive investigation. The knowledge of mechanistic understanding of structure-membrane interactions relationship of drugs will not only provide useful insights to receptor binding kinetics, but also enhance our ability to take advantage of the apparent membrane contributions in rational design of drugs targeting transmembrane proteins with improved efficacy and safety. In this minireview, we summarize recent structural and computational studies in this direction, elucidating lipid pathways of ligand access and binding mechanisms for several orthosteric and allosteric ligands of class A and class B GPCRs.

  • Allosterism
  • Computational drug design
  • Drug discovery
  • G protein-coupled receptors (GPCRs)
  • Membrane permeability
  • Molecular modeling
  • Pharmacodynamics
  • Pharmacokinetics
  • Phospholipids
  • Structure-activity relationships
  • The American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Molecular Pharmacology: 103 (3)
Molecular Pharmacology
Vol. 103, Issue 3
1 Mar 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Does the lipid bilayer orchestrate access and binding of ligands to transmembrane orthosteric/allosteric sites of GPCRs?
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleMinireview

Does the lipid bilayer orchestrate access and binding of ligands to transmembrane orthosteric/allosteric sites of GPCRs?

Christopher Tytus Szlenk, Jeevan B GC and Senthil Natesan
Molecular Pharmacology April 8, 2019, mol.118.115113; DOI: https://doi.org/10.1124/mol.118.115113

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleMinireview

Does the lipid bilayer orchestrate access and binding of ligands to transmembrane orthosteric/allosteric sites of GPCRs?

Christopher Tytus Szlenk, Jeevan B GC and Senthil Natesan
Molecular Pharmacology April 8, 2019, mol.118.115113; DOI: https://doi.org/10.1124/mol.118.115113
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ferroptosis and Breast Cancer
  • LncRNAs Associated With Neuroinflammation
  • AhR modulation in environmentally induced skin conditions
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics